MedTrace Logo

Efficacy and Safety of Astaxanthin in Volunteer With Refraction Errors

NCT05009810 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2021-08-18

No results posted yet for this study

Summary

This study will investigate efficacy and safety of astaxanthin in 180 volunteers with refraction errors. Visual test, skin test, liver function test, renal function test, and adverse event will be evaluated before and after taking astaxanthin for 1 and 2 months.

Conditions

  • Refractive Errors

Interventions

DIETARY_SUPPLEMENT

astaxanthin 4 mg

They will take astaxanthin 4 mg 1 capsule once daily for 2 months.

DIETARY_SUPPLEMENT

astaxanthin 6 mg

They will take astaxanthin 6 mg 1 capsule once daily for 2 months.

DIETARY_SUPPLEMENT

Placebo

They will take placebo 1 capsule once daily for 2 months.

Sponsors & Collaborators

  • Chulalongkorn University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-08-15
Primary Completion
2022-06-30
Completion
2022-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05009810 on ClinicalTrials.gov